01561nam 2200397 450 991071509760332120221025075534.0(CKB)4100000011920094(NjHacI)994100000011920094(OCoLC)1202625853(OCoLC)1227256149(EXLCZ)99410000001192009420221025d2019 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierRisk of nephrogenic systemic fibrosis after exposure to newer gadolinium agents /Karen M. Goldstein [and two others]Washington, DC :U.S. Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service,2019.1 online resource (vi, 111 pages) illustrationsEvidence-based synthesis program (Series)"October 2019."Includes bibliographical references.Evidence-based synthesis program (Series)Contrast media (Diagnostic imaging)United StatesfastContrast media (Diagnostic imaging)572Goldstein Karen M.1353976United States.Department of Veterans Affairs.Health Services Research and Development Service,NjHacINjHaclBOOK9910715097603321Risk of nephrogenic systemic fibrosis after exposure to newer gadolinium agents3291168UNINA